Clinical Trial Update: SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot [Phase 1, Phase 2]

View source ↗

Summary

A pilot study evaluating the effects of an SGLT2 inhibitor on inflammation and cardiovascular outcomes in obesity with pre-diabetes; results completed and poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Pre-diabetes

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Obesity, Pre-diabetes | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-02-01